Prelude Therapeutics Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PRLD Nasdaq 2836 preludetx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Prelude Therapeutics Incorporated

December 2025's Intriguing Stocks Priced Below Estimated Value - Dec 30th, 2025 10:38 am
3 Promising Penny Stocks With A Market Cap Below $400M - Dec 30th, 2025 5:05 am
Celsius Holdings Among 3 Value Stocks Trading Below Estimated Worth - Dec 30th, 2025 4:37 am
Prelude Therapeutics Incorporated's (NASDAQ:PRLD) Path To Profitability - Dec 29th, 2025 4:24 am
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs - Dec 6th, 2025 9:00 am
Penny Stocks To Consider In December 2025 - Dec 1st, 2025 11:05 am
Prelude Therapeutics Inc (PRLD) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Nov 12th, 2025 2:01 pm
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 12th, 2025 5:01 am
Prelude Therapeutics (PRLD): Valuation Snapshot Following Incyte Deal and Pipeline Realignment - Nov 7th, 2025 10:18 pm
Prelude Therapeutics (PRLD) Is Up 14.3% After Incyte Option Deal and Pipeline Shift Has the Bull Case Changed? - Nov 5th, 2025 5:18 am
Prelude Therapeutics Announces Strategic Business Update - Nov 4th, 2025 5:05 am
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors - Nov 4th, 2025 5:01 am
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Nov 3rd, 2025 7:01 am
3 Compelling Penny Stocks With Market Caps Under $600M - Oct 27th, 2025 6:15 am
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors - Oct 17th, 2025 5:30 am
3 Promising Penny Stocks With Over $60M Market Cap - Sep 26th, 2025 12:05 pm
3 Promising Penny Stocks With Market Caps Under $300M - Aug 26th, 2025 12:08 pm
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 14th, 2025 5:00 am
Can Prelude Therapeutics (NASDAQ:PRLD) Afford To Invest In Growth? - Aug 11th, 2025 5:32 am
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences - Jun 2nd, 2025 5:30 am